参考文献/References:
[1]FANG X, YU M, ZHENG D, et al. Electrophysiologic characteristics of nitrous-oxide-associated peripheral neuropathy: a retrospective study of 76 patients[J]. J Clin Neurol, 2023, 19(1): 44-51.
[2]李 妍,张秀春,赵传胜. 笑气滥用致周围神经病的神经电生理特征分析[J]. 中国医科大学学报,2022,51(1):86-90.
[3]HASHEM MM, ESMAEL A, NASSAR AK, et al. The relationship between exacerbated diabetic peripheral neuropathy and metformin treatment in type 2 diabetes mellitus [J].Sci Rep, 2021, 11(1): 1940-1948.
[4]KAMBOJ SK, ZHAO H, TROEBINGER L, et al. Rewarding subjective effects of the NMDAR antagonist nitrous oxide(laughing gas) are moderated by impulsivity and depressive symptoms in healthy volunteers [J]. Int J Neuropsychopharmacol, 2021, 24(7): 551-561.
[5]CARIS MG, KUIPERS RS, KIESTRA BE, et al. Nitrousoxide abuse leading to extreme homocysteine levels and thrombosis in young adults: a case series[J]. J Thromb Haemost, 2023, 21(2): 276-283.
[6]TEMPLE C, HOROWITZ BZ. Nitrous oxide abuse induced subacute combined degeneration despite patient initiated B12 supplementation [J]. Clin Toxicol (Phila), 2022, 60(7): 872-875.
[7]NABBEN T, WEIJS J, VAN AMSTERDAM J. Problematic use of nitrous oxide by young moroccan-dutch adults [J]. Int J Environ Res Public Health, 2021, 18(11):5574-5590.
[8]GREENSTEIN AM, SHERRATT K, MANGWIRO R. Postpartum peripheral neuropathy due to vitamin B12 deficiency, potentially precipitated by nitrous oxide use [J]. Anaesth Rep, 2023, 11(1): e12229.
[9]GRZYCH G, DEHEUL S, GERNEZ E, et al. Comparison of biomarker for diagnosis of nitrous oxide abuse: challenge of cobalamin metabolic parameters, a retrospective study [J]. J Neurol, 2023, 270(4): 2237-2245.
[10]LARGEAU B, KARAM A, POTEY C, et al. Myeloneuropathy induced by recreational nitrous oxide use with variable exposure levels [J]. Eur J Neurol, 2022, 29(8): 2173-2180.
[11]叶建锋,汪志忠,盛柳青,等. 神经电生理监测及多模态影像融合技术在面肌痉挛微血管减压术中的应用[J]. 中国临床神经外科杂志,2023,28(2):109-110.